Familial ligand-defective apolipoprotein B-100: Detection, biochemical features and haplotype analysis of the R3531C mutation in the UK

Atherosclerosis

Volumn 129, Issue 2, 1997, Pages 185-192

  Wenham, Philip R ^a   Henderson, Bryony G ^a   Penney, Michael D ^b   Ashby, J Peter ^a   Rae, Peter W H ^a   Walker, Simon W ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

apolipoprotein B 100; familial ligand defective apolipoprotein B 100; heteroduplex analysis; hypercholesterolemia; polymerase chain reaction

Indexed keywords

APOLIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DISORDER; GENE MUTATION; GENOME; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CODON; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GREAT BRITAIN; HAPLOTYPES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIGANDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PEDIGREE; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, LDL;

EID: 0030989827     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06029-7     Document Type: Article

References (37)

1. Innerarity TL, Mahley RW, Weisgraber KH et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolaemia. J Lipid Res 1990;31:1337-1349.
2. Tybjærg-Hansen A, Humphries SE. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis 1992;96:91-107.
3. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis 1993;104:1-18.
4. Soria LF, Ludwig EH, Clark HRG, Vega GL, Grundy S M, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989;86:587-591.
5. Knott TJ, Wallis SC, Powell LM et al. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res 1986;14:7501-7503.
6. Marz W, Baumstark MW, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J. Accumulation of 'small dense' low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterogeneous interaction of LDL subfractions with the LDL receptor. J Clin Invest 1993;92:2922-2933.
7. Pullinger CR, Hennessy LK, Chatterton JE et al. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995;95:1225-1234.
8. Gaffney D, Reid JM, Cameron I M et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscler Thromb Vasc Biol 1995;15:1025-1029.
9. Wenham PR, Bloomfield P, Blundell G, Penney MD, Rae PWH, Walker SW. Familial defective apolipoprotein B-100: a study of patients from lipid clinics in Scotland and Wales. Ann Clin Biochem 1996;33:443-450.
10. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary disease in familial hypercholesterolaemia. Br Med J 1991;303:893-896.
11. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
12. Myant NB, Gallagher JJ, Knight BL et al. Clinical signs of familial hypercholesterolaemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein function. Arterioscler Thromb 1991;11:691-703.
13. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cell. Nucleic Acids Res 1988;16:1215.
14. Kotze MJ, Langenhoven E, Peeters AV, Theart L, Oosthuizen CJJ. Detection of two point mutations causing familial defective apolipoprotein B-100 by heteroduplex analysis. Mol Cell Prob 1994;8:513-518.
15. Tybjærg-Hansen A, Gallagher J, Vincent J et al. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis 1990;80:235-242.
16. Motti C, Funke H, Rust S, Dergunov A, Assman G. Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin Chem 1991;37:1762-1766.
17. Priestly L, Knott T Wallis S, Powell L, Pease R, Simon A, Scott J. RFLP for the human apolipoprotein B gene: i, Bam HI; ii, Eco RI; iii, Eco RV; iv, Msp I; v, Xba I. Nucleic Acids Res 1985;13:6789-6794.
18. Wu M-J, Bütler E, Bütler R, Schumaker VN. Identification of the base substitution responsible for the Ag (x/y) polymorphism of apolipoprotein B-100. Arterioscler Thromb 1991;11:379-384.
19. Huang L-S, de Graff J, Breslow JL. Apo B gene Msp I RFLP in exon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res 1988;29:63-67.
20. Shoulders CC, Myant N, Sidoli A et al. Molecular cloning of human apolipoprotein B cDNA: Evidence for more than one gene per haploid genome. Atherosclerosis 1985;58:277-289.
21. Dunning AM, Renges H-H, Xu C-F et al. Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3′ end of the human gene. Am J Hum Genet 1992;50:208-221.
22. Boerwinkle E, Xiong W, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 1989;86:212-216.
23. Ludwig EH, Friedl W, McCarthy BJ. High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Hum Genet 1989;45:458-464.
24. Talmud P, Tybjærg-Hansen A, Bhatnager D et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991;89:137-141.
25. Webb JC, Sun X-M, Patel DD, McCarthy SN, Knight BL, Soutar AK. Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolaemia. J Lipid Res 1992;33:689-698.
26. Soutar AK, Knight BL, Patel DD. Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolaemia that ligand binding and intracellular movement of receptors. Proc Natl Acad Sci USA 1989;86:4166-4170.
27. Wenham PR, Panarelli M, Bloomfield P et al. Identification and detection of a point mutation in codon 80 of the low density lipoprotein receptor gene by PCR-mediated mutagenesis. Proc ACB National Meeting 1995; Abstract:92-93.
28. Jensen LG, Jensen HK, Kjeldsen M et al. A new highly informative Sma I polymorphism in intron 7 of the low density lipoprotein receptor (LDLR) gene. Clin Genet 1994;45:52-53.
29. Leitersdorf E, Chakravart, A, Hobbs HH. Polymorphic DNA haplotypes at the LDL receptor locus. Am J Hum Genet 1989;44:409-421.
30. Leitersdorf E, Hobbs HH. Human LDL receptor gene: Hinc II polymorphism detected by gene amplification. Nucleic Acids Res 1988;16:7215.
31. Saint-Jore B, Loux N, Boileau C. Two new polymorphisms in the coding sequence of the LDL receptor (LDLR) gene. Hum Genet 1993;91:511-512.
32. Miserez AR, Laager R, Chiodetti N, Keller U. High prelavence of familial defective apolipoprotein B-100 in Switzerland. J Lipid Res 1994;35:574-583.
33. Kotze MJ, Peeters AV, Langenhoven E, Wauters JG, Van Gaal LF. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolaemics. Atherosclerosis 1994;111:217-225.
34. Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M. Genotypic and phenotypic variation in familial hypercholesterolaemia. Arteriosclerosis 1989;9:(Suppl) I-75-I-80.
35. Miserez AR, Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol 1995;15:1719-1729.
36. Youssoufian H, Kazazian H Jr, Phillips DG et al. Recurrent mutations in haemophilia A give evidence for CpG mutation hot spots. Nature 1986;324:380-382.
37. Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 1984;36:131-138.